CVS Group Plc (CVSG.L), a British veterinary services provider, on Thursday reported that its first-half adjusted EBITDA, a key earnings metric, increased 4.5% to 67.4 million pounds from last year's 64.5 million pounds.
Adjusted EBITDA margin was 19.7%, in line with target EBITDA margins.
In the six-month period to December 31, Group sales increased 6.6% to 341.8 million pounds from prior year's 320.5 million pounds.
Group like-for-like sales for the period were down 1.1% impacted by a continuation of softer market conditions in the UK most notably in online retail and laboratory businesses.
Looking ahead, the company said its Board remains confident in the Group delivering full year 2025 results in line with market expectations.
The Company expects to announce its first-half interim results on February 27.
For comments and feedback: editorial@rttnews.com